BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 294 filers reported holding BLUEBIRD BIO INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,807,000 | -12.7% | 252,100 | -6.1% | 1.13% | -20.9% |
| Q2 2018 | $42,141,000 | -7.6% | 268,500 | +0.5% | 1.43% | -18.7% |
| Q1 2018 | $45,607,000 | -1.4% | 267,100 | +2.8% | 1.76% | -12.5% |
| Q4 2017 | $46,270,000 | +393.5% | 259,800 | +154.1% | 2.01% | +97.1% |
| Q4 2014 | $9,376,000 | – | 102,227 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
| RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
| APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
| Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
| Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
| RA Capital Management | 167,367 | $14,318,000 | 2.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
| Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
| Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
| CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |